https://ted.europa.eu/udl?uri=TED:NOTICE:22439-2024:TEXT:EN:HTML&src=0

오늘은 셀트리온이 합병으로 첫 거래일인데 ..

마음이 안좋네요...

하지만 회사는 열심히 일은하고 있는것 같네요 ...

힘들지만 다같이 힘내시고...

주말은 가족과 즐거운 주말 보내세요....

TED 의약품 네덜란드 낙찰 소식이 있어 공유 드립니다.

6.1.2 Information about

Winner:Official name: Celltrion Healthcare Netherlands BV

Tender:Tender identifier: Celltrion Healthcare Netherlands BVIdentifier of lot or group of lots: LOT-0004

Value of the result: 659,869 EUR (한화 : 9억 5천만원 정도)

Subcontracting: noSubcontracting value is known: No

Subcontracting percentage is known: No

Contract information:Identifier of the contract: 2023-0232 4-4

Title: Bevacizumab - Injectable

Date of the conclusion of the contract: 2023-11-22+01:00

The contract is awarded within a framework agreement: falseOrganisation signing the contract: HUmani SC

8.1 ORG-0009

Official name: Celltrion Healthcare Netherlands BV

Size of the economic operator: sme

Registration number: NL8584.72.090.B.01

Postal address: Pietersbergweg 199  Town: AmsterdamPostcode: 1105BM

Country: NetherlandsEmail: celltrionhc.com">nicolas.vangelder@celltrionhc.com

Telephone: +32 496813486

Roles of this organisation:Tenderer

Winner of these lots: LOT-0004

The winner is listed on a regulated market